These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24417355)

  • 21. QNA-Based Prediction of Sites of Metabolism.
    Tarasova O; Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29194399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System.
    He SB; Li MM; Zhang BX; Ye XT; Du RF; Wang Y; Qiao YJ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27735849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classification of cytochrome p(450) activities using machine learning methods.
    Hammann F; Gutmann H; Baumann U; Helma C; Drewe J
    Mol Pharm; 2009; 6(6):1920-6. PubMed ID: 19813762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals.
    Rendic S; Guengerich FP
    Chem Res Toxicol; 2015 Jan; 28(1):38-42. PubMed ID: 25485457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
    Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
    Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CYPstrate: A Set of Machine Learning Models for the Accurate Classification of Cytochrome P450 Enzyme Substrates and Non-Substrates.
    Holmer M; de Bruyn Kops C; Stork C; Kirchmair J
    Molecules; 2021 Aug; 26(15):. PubMed ID: 34361831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network.
    Li X; Xu Y; Lai L; Pei J
    Mol Pharm; 2018 Oct; 15(10):4336-4345. PubMed ID: 29775322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
    Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
    Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Site of metabolism prediction for six biotransformations mediated by cytochromes P450.
    Zheng M; Luo X; Shen Q; Wang Y; Du Y; Zhu W; Jiang H
    Bioinformatics; 2009 May; 25(10):1251-8. PubMed ID: 19286831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into molecular basis of cytochrome p450 inhibitory promiscuity of compounds.
    Cheng F; Yu Y; Zhou Y; Shen Z; Xiao W; Liu G; Li W; Lee PW; Tang Y
    J Chem Inf Model; 2011 Oct; 51(10):2482-95. PubMed ID: 21875141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved Prediction of CYP-Mediated Metabolism with Chemical Fingerprints.
    Zaretzki J; Boehm KM; Swamidass SJ
    J Chem Inf Model; 2015 May; 55(5):972-82. PubMed ID: 25871613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. XenoSite server: a web-available site of metabolism prediction tool.
    Matlock MK; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Apr; 31(7):1136-7. PubMed ID: 25411327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
    Labroo RB; Paine MF; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
    Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
    J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
    Doehmer J; Weiss G; McGregor GP; Appel K
    Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity.
    Zhang T; Dai H; Liu LA; Lewis DF; Wei D
    Mol Inform; 2012 Jan; 31(1):53-62. PubMed ID: 27478177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR Modeling and Prediction of Drug-Drug Interactions.
    Zakharov AV; Varlamova EV; Lagunin AA; Dmitriev AV; Muratov EN; Fourches D; Kuz'min VE; Poroikov VV; Tropsha A; Nicklaus MC
    Mol Pharm; 2016 Feb; 13(2):545-56. PubMed ID: 26669717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.